2024 HCPCS Code Q2056
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: ciltacabtagene directed preparation maturation leukapheresis antigen autologous therapeutic million
| Short Description | Ciltacabtagene car-pos t |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | October 01, 2022 |
| HCPCS Code Added Date | October 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q5105 - Inj retacrit esrd on dialysi
- Q5106 - Inj retacrit non-esrd use
- Q5107 - Inj mvasi 10 mg
- Q5108 - Injection, fulphila
- Q5109 - Injection, ixifi, 10 mg
- Q5110 - Nivestym
- Q5111 - Injection, udenyca 0.5 mg
- Q5112 - Inj ontruzant 10 mg
- Q5113 - Inj herzuma 10 mg
- Q5114 - Inj ogivri 10 mg
- Q5115 - Inj truxima 10 mg
- Q5116 - Inj., trazimera, 10 mg
- Q5117 - Inj., kanjinti, 10 mg
- Q5118 - Inj., zirabev, 10 mg
- Q5119 - Inj ruxience, 10 mg
- Q5120 - Inj pegfilgrastim-bmez 0.5mg
- Q5121 - Inj. avsola, 10 mg
- Q5122 - Inj, nyvepria
- Q5123 - Inj. riabni, 10 mg
- Q5124 - Inj. byooviz, 0.1 mg